Katherine Anagnostopoulou

Katherine Anagnostopoulou

Auto-generated profile, based on publicly available information

Katherine Anagnostopoulou

Department of Molecular Genetics, Genomedica S.A.

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Maturitas
Verified
Journal Article
Closed access
GKGenovefa D Kolovou
Genovefa D Kolovou
KAKatherine K. Anagnostopoulou
Katherine K. Anagnostopoulou
APAntonis N. Pavlidis
Antonis N. Pavlidis
KSKlelia D. Salpea
Klelia D. Salpea
IHIoannis S. Hoursalas
Ioannis S. Hoursalas
DCDennis V Cokkinos
Dennis V Cokkinos

1 January 2006 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
GKGenovefa D Kolovou
Genovefa D Kolovou
KAKatherine K. Anagnostopoulou
Katherine K. Anagnostopoulou
KSKlelia D. Salpea
Klelia D. Salpea
NPNektarios D. Pilatis
Nektarios D. Pilatis
GGGeorgia Grapsa
Georgia Grapsa
SIStella Iraklianou
Stella Iraklianou

1 May 2004 in Angiology
Verified
Journal Article
Closed access
GKGenovefa D Kolovou
Genovefa D Kolovou
DDDeliana Daskalova
Deliana Daskalova
IMIrene Mastorakou
Irene Mastorakou
KAKatherine Anagnostopoulou
Katherine Anagnostopoulou
DCDennis V Cokkinos
Dennis V Cokkinos
Familial hypercholesterolemia (FH) is a relatively common autosomal monogenic disease with dominant inheritance and threefold to fourfold increase in relative risk of cardiovascular death in untreated patients. For a “definitive” clinical diagnosis of FH the Simon Broome Register proposes the presence of tendon xanthomas as a key feature. However, detection of tendon xanthomas by physical examination is subjective and difficult to use for follow-up purposes. Several instrumental methods have been reported to be more sensitive than physical examination for the evaluation of xanthomas. The present case illustrates the usefulness of computed tomography (CT) to detect xanthomas in the Achilles tendons (XAT) and their regression in response to hypolipidemic drug treatment in a heterozygous FH patient. As XAT are atherosclerotic plaque-like depositions of lipids it is likely that their progression or regression follows the behavior of vascular atherosclerotic lesions.

1 January 2010 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
PKPeggy Kostakou
Peggy Kostakou
GKGenovefa D Kolovou
Genovefa D Kolovou
KAKatherine Anagnostopoulou
Katherine Anagnostopoulou
TTTheodor Theodoridis
Theodor Theodoridis
VGVassiliki Galea
Vassiliki Galea
DCDennis V Cokkinos
Dennis V Cokkinos

25 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ASAinara Salazar-Villacorta
Ainara Salazar-Villacorta
LBLaura M. Bond
Laura M. Bond
LKLeehyeon Kim
Leehyeon Kim
KAKatherine Anagnostopoulou
Katherine Anagnostopoulou
ASAnnarita Scardamaglia
Annarita Scardamaglia
RFRobert V. Farese
Robert V. Farese
FITM2 encodes fat-storage inducing transmembrane protein 2 (FIT2), a lipid diphosphatase in the ER that cleaves acyl-CoAs and is crucial for ER homeostasis. In humans, homozygous null mutations in FITM2 are associated with a syndrome characterized by deafness and dystonia. Here, we report two families with hereditary spastic paraplegia (HSP) in whom exome sequencing revealed compound heterozygosity for FITM2 mutations. In each family, the affected probands carry one putative null allele and one G100R missense allele. Functional analyses demonstrated that the G100R allele is hypomorphic, with FIT2 protein levels reduced to 20% of wild type, leading to proportionately decreased enzyme activity. The occurrence of similar HSP disease phenotypes and the same hypomorphic mutation in these families suggests that the G100R mutation and its associated reduced enzyme activity represent a newly recognized clinical manifestation of FITM2 mutations, expanding the spectrum of conditions associated with this gene.